Which has grown faster, INVA or OCUL?

Over the past five years, OCUL grew revenue faster — INVA at a 3.94% CAGR versus OCUL at 10.03%.

Is INVA or OCUL more profitable?

INVA runs the higher net margin — INVA at 80.56% versus OCUL at -579.10%.

How have INVA and OCUL total returns compared?

Over the past 10 years, INVA delivered 6.43% and OCUL delivered 0.44% annualized total return. Past performance doesn't predict future results.

Innoviva, Inc. (INVA) vs Ocular Therapeutix, Inc. (OCUL)

A side-by-side comparison of Innoviva, Inc. and Ocular Therapeutix, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

INVA

Innoviva, Inc.

$1.54B

$20.90HealthcareDelayed quote: Oct 6, 2026, 12:25 PM EDT

OCUL

Ocular Therapeutix, Inc.

$1.63B

$7.43HealthcareDelayed quote: Oct 6, 2026, 12:20 PM EDT

Total return — INVA vs OCUL

growth of $100 · dividends reinvested · last 10y

INVA +94.5% (+6.9%/yr)OCUL +12.9% (+1.2%/yr)INVA compounded faster over this window

INVA OCUL

INVA vs OCUL: by the numbers

•OCUL is the larger company ($1.63B vs $1.54B market cap).
•INVA is profitable (80.56% net margin) while OCUL runs a net loss (-579.10%).
•OCUL grew revenue faster over the past five years (10.03% vs 3.94% CAGR).

Metrics side by side

Valuation

Metric	INVA	OCUL
P/E ratio	5.10	N/A
Forward P/E	8.64	N/A
PEG ratio	0.49	N/A
P/S ratio	3.48	31.25
P/B ratio	1.25	3.13
EV / EBITDA	4.92	N/A
FCF yield	12.21%	N/A

Profitability

Metric	INVA	OCUL
Gross margin	73.09%	87.11%
Operating margin	36.66%	-521.04%
Net margin	80.56%	-579.10%
ROE	28.97%	-57.97%
ROIC	8.36%	-50.20%

Growth (annualized)

Metric	INVA	OCUL
Revenue CAGR (5Y)	3.94%	10.03%
EPS CAGR (5Y)	12.71%	N/A
FCF CAGR (5Y)	-10.54%	N/A
Total return CAGR (5Y)	4.52%	-5.73%

Frequently asked

Which has grown faster, INVA or OCUL?: Over the past five years, OCUL grew revenue faster — INVA at a 3.94% CAGR versus OCUL at 10.03%.
Is INVA or OCUL more profitable?: INVA runs the higher net margin — INVA at 80.56% versus OCUL at -579.10%.
How have INVA and OCUL total returns compared?: Over the past 10 years, INVA delivered 6.43% and OCUL delivered 0.44% annualized total return. Past performance doesn't predict future results.

Go deeper

Full INVA analysis Full OCUL analysis Interactive comparison tool

Dig into the metrics

Innoviva P/E ratio Innoviva ROE Ocular Therapeutix ROE Innoviva operating margin Ocular Therapeutix operating margin Innoviva revenue growth Ocular Therapeutix revenue growth Innoviva free cash flow Ocular Therapeutix free cash flow

Innoviva & Ocular Therapeutix appear in these rankings

Highest ROE Stocks Highest Operating Margin Stocks Highest FCF Yield Stocks Lowest P/E Ratio Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.